TRAVERSA SERGIO 4
4 · RELMADA THERAPEUTICS, INC. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2024-01-29$3.71/sh+31,541$117,036→ 175,565 total - Purchase
Common Stock
2024-01-30$3.90/sh+40,999$159,949→ 216,564 total - Purchase
Common Stock
2024-01-31$4.00/sh+27,460$109,752→ 244,024 total
Footnotes (4)
- [F1]The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
- [F2]Purchase prices range from $3.69 to $3.75 per share, inclusive.
- [F3]Purchase prices range from $3.88 to $3.97 per share, inclusive.
- [F4]Purchase prices range from $3.95 to $4.05 per share, inclusive.